Stockscreener 앱 받기
325.92
1.21%
3.91
전일 마감가:
$322.01
열려 있는:
$323.5
하루 거래량:
1.02M
Relative Volume:
1.06
시가총액:
$23.03B
수익:
$3.22B
순이익/손실:
$542.70M
주가수익비율:
43.57
EPS:
7.4805
순현금흐름:
$458.00M
1주 성능:
+8.39%
1개월 성능:
+22.56%
6개월 성능:
+20.25%
1년 성능:
+51.77%
1일 변동 폭
$316.10
$328.44
1주일 범위
$298.45
$328.44
52주 변동 폭
$202.79
$328.44
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
325.92 | 23.03B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
450.06 | 159.39B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
149.43 | 41.17B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
39.52 | 33.42B | 29.14B | 1.07B | 1.52B | 1.1995 |
ALC
Alcon Inc
|
62.56 | 30.51B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
206.76 | 29.99B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services stock hits 52-week high at $322.40 By Investing.com - Investing.com Australia
WST (NYSE) Form 144 lists proposed sale of vested common stock lots - Stock Titan
West Pharmaceutical Services stock hits 52-week high at $322.40 - Investing.com
West Pharmaceutical Services (WST) just flashed golden cross signal: Do you buy? - MSN
This pharma stock is soaring after earnings. It’s a sneaky GLP-1 play. - MSN
West Pharmaceutical Services (WST) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo! Finance Canada
West Pharma jumps as packaging components drive strong Q1 beat - MSN
West Pharmaceutical to Present at May, June Investor Conferences - MyChesCo
Director at West Pharmaceutical (WST) receives 791 restricted stock units - Stock Titan
West Pharmaceutical (NYSE: WST) director awarded 791 restricted stock units in equity grant - Stock Titan
West Pharmaceutical (NYSE: WST) director granted 791 restricted stock units - Stock Titan
West Pharmaceutical (WST) director granted 791 restricted stock units - Stock Titan
[Form 4] WEST PHARMACEUTICAL SERVICES INC Insider Trading Activity - Stock Titan
Director at West Pharmaceutical (NYSE: WST) awarded 791 shares - Stock Titan
Director Robert Friel gets 791 RSUs at West Pharma (NYSE: WST) - Stock Titan
West Pharmaceutical (NYSE: WST) director receives 791 restricted stock units award - Stock Titan
Director at West Pharmaceutical (NYSE: WST) granted 791 RSUs - Stock Titan
West Pharmaceutical Services, Inc. Form 8-K Filing Details for May 4, 2026 – Company Information, Security Details, and Compliance Disclosures - Minichart
West Pharmaceutical Shareholders Back Board, Pay and Auditor - TipRanks
wst-20260504 - SEC.gov
West Pharmaceutical shareholders elect directors and approve executive pay - Investing.com
Declaration of Voting Results by West Pharmaceutical - marketscreener.com
West Pharmaceutical (NYSE: WST) backs board, pay and rejects chair policy - Stock Titan
Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down - TradingView
RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution - TradingView
West to Host First-Quarter 2026 Conference Call - Quantisnow
West Pharmaceutical Services (WST): An In-Depth Stock Analysis Reveals 16.35% Potential Upside - DirectorsTalk Interviews
Jennison Associates LLC Grows Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Is West Pharmaceutical Services (WST) Pricing Look Stretched After Strong 1 Year Rally? - Yahoo Finance
WST Stock Price Prediction 2025-2026 | West Pharmaceutical Services Inc Forecast | 24/7 Wall St. - 24/7 Wall St.
West Pharmaceutical Reports Higher First-Quarter Revenue, Earnings - MyChesCo
Reasons to retain West Pharmaceutical stock in your portfolio for now - MSN
How Strong Q1 Results, Higher 2026 Guidance, and a $298 Million Buyback At West (WST) Has Changed Its Investment Story - Sahm
West Pharmaceutical: Multiple Growth Drivers Are A Tailwind (NYSE:WST) - Seeking Alpha
WST stock jumps on Q1 earnings & sales beat, EPS view up on HVP growth - MSN
The Top 5 Analyst Questions From West Pharmaceutical Services’s Q1 Earnings Call - The Globe and Mail
Insider Selling: West Pharmaceutical Services (NYSE:WST) CAO Sells 896 Shares of Stock - MarketBeat
West Pharmaceutical Services Reclaims Momentum with Q1 2026 Earnings Beat - HarianBasis.co
Vanguard Portfolio Management holds 4.10M WST shares (5.69%) — WST - Stock Titan
WST | West Pharmaceutical Services, Inc. Insider Trading - Quiver Quantitative
West Pharmaceutical sr. VP Annette Favorite sells $859,753 in shares By Investing.com - Investing.com Australia
West Pharmaceutical Services Insider Sold Shares Worth $859,753, According to a Recent SEC Filing - marketscreener.com
West Pharmaceutical sr. VP Annette Favorite sells $859,753 in shares - Investing.com
West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $859K - TradingView
WST chief accounting officer Chad Winters sells $269,399 in stock - Investing.com
West Pharmaceutical (WST) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Are You Looking for a Top Momentum Pick? Why West Pharmaceutical Services (WST) is a Great Choice - Yahoo Finance
Best Momentum Stocks to Buy for April 29th - The Globe and Mail
West Pharmaceutical Services, Inc. $WST Shares Purchased by Comerica Bank - MarketBeat
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
2.41%
자본화:
|
볼륨(24시간):